| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5536177 | Tuberculosis | 2017 | 6 Pages |
Abstract
The time-kill kinetics assay provides important information on the mycobacterial killing dynamics of anti-tuberculosis drugs during the early phase of drug exposure. As such, this assay is a valuable component of the preclinical modeling framework.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Hannelore I. Bax, Irma A.J.M. Bakker-Woudenberg, Corné P. de Vogel, Aart van der Meijden, Annelies Verbon, Jurriaan E.M. de Steenwinkel,